About Sameer Rohatgi
Form D filings for CytoTronics in 2024 list Sameer Rohatgi as director.
Sameer Rohatgi first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Sameer Rohatgi in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sameer Rohatgi works with at each company, as listed on that company's latest Form D.
CytoTronics, Inc. · Form D, Oct 11, 2024
JA
Jeffrey Abbott
Chief Executive Officer and director
DK
Douglas Kahn
Director
WW
Wenxuan Wu
Executive officer and director
JA
Jenna Abelli
Director